Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-02-06
1998-06-02
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 77, C07D24112, A61K 31495
Patent
active
057600457
ABSTRACT:
Described are new delta-17 and delta-20 olefic and saturated 17.beta.-substituted 4-aza-5.alpha.-androstan-3-ones and related compounds and the use of such compounds as 5.alpha.-reductase inhibitors for treatment of benign prostatic hyperplasia and other hyperandrogenic related disorders.
REFERENCES:
patent: 4220775 (1980-09-01), Rasmusson et al.
patent: 4377584 (1983-03-01), Rasmusson et al.
patent: 4596812 (1986-06-01), Chidsey, III et al.
patent: 4732897 (1988-03-01), Cainelli
patent: 4760071 (1988-07-01), Rasmusson et al.
patent: 4859681 (1989-08-01), Rasmusson et al.
patent: 4882319 (1989-11-01), Holt et al.
patent: 4888336 (1989-12-01), Holt et al.
patent: 4910226 (1990-03-01), Holt et al.
patent: 5049562 (1991-09-01), Rasmusson et al.
patent: 5084574 (1992-01-01), Bhattachayra et al.
patent: 5110939 (1992-05-01), Holt
patent: 5116983 (1992-05-01), Bhattacharya et al.
patent: 5120742 (1992-06-01), Rasmusson et al.
patent: 5175155 (1992-12-01), Juniewicz et al.
patent: 5510351 (1996-04-01), Graham et al.
patent: 5510485 (1996-04-01), Graham et al.
patent: 5595996 (1997-01-01), Graham et al.
The Daily (Tuesday, May 7, 1996), "New Data on Proscar, Abbott's Hytrin Show Conflicting Results".
Wall Street Journal ( Tuesday, May 7, 1996), "Study Finds Abbott's Prostate Drug is Much More Effective than Merck's", p. B4.
US News & World Report, May 20, 1996, "Zapping a problem prostate".
Rasmusson et al., J. Med. Chem., 29(11), (1986), pp. 2298-2315, "Aza steroids: structure-activity relationships . . . ".
Brooks et al, Prostate (1986), 9(1), pp. 65-75, "Prostatic effects induced in dogs by . . . 5 alpha-reductase inhibitors".
Brooks et al., Steroids (1986), 47(1), pp. 1-19, "5 alpha-reductase inhibitory . . . activities of some 4-aza-steroids in the rat".
Liang et al., Endo. (1985) 117(2), pp. 571-579, "Species differences in prostatic steroidal 5 alpha-reductases of rat, dog, and human".
Rasmusson et al., J. Med. Chem. (1984) 27(12), pp. 1690-1701, "Azasteroids as inhibitors of rat prostatic 5 alpha-reductase".
Kadohama et al., JNCL, vol. 74, No. 2, pp. 475-481, "Retardation of prostate tumor progression in the noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductas".
Brooks et al., Steroids, vol. 18 (1991), pp. 215-227, "Effect of castration, DES, flutamide, and MK-906 on growth of the dunning rat prostatic carcinoma . . . ".
Labrie et al., Lancet, (1986), No. 8515, pp. 1095-1096, "Combination therapy in prostate cancer".
Stinson, Chem & Eng News (Jun. 29, 1992), pp. 7-8, "Prostate drug Proscar cleared for marketing".
Helliker, Wall Street Journal (Jun. 7, 1991), pp. A1 and A7, "Alopecia sufferers seek to suffer less and not in silence" Burger, Medicinal Chemistry 2nd ed., Interscience , New York (1960), p. 42.
Burger, "Medicinal Chemistry 2nd ed.", Interscience, New York (1960), p. 42.
Back et al., J. Organic Chem., vol 54 (1989), pp. 1904-1910 "N-chloroazasteroids: a novel class of reactive steroid analogues . . . ".
Diani et al., J. Clin. Endoc. and Metab., vol. 74, No. 2, pp. 345-350 (1990), "Hair growth effects of oral administration of finasteride".
Geldof et al., J. Cancer Res. Clin. Oncol., vol. 118 (1992), pp. 50-55, "Consideration of the use of . . . 4MA . . . in prostate cancer therapy".
Aster Susan D.
Graham Donald W.
Tolman Richard L.
Daus Donald G.
Fitch Catherine D.
Merck & Co. , Inc.
Winokur Melvin
LandOfFree
Delta-17 and delta-20 olefinic and saturated 17.beta.-substitute does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delta-17 and delta-20 olefinic and saturated 17.beta.-substitute, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delta-17 and delta-20 olefinic and saturated 17.beta.-substitute will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1460113